摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(cyclobutyl)-1,3-thiazol-2-amine | 475058-07-2

中文名称
——
中文别名
——
英文名称
4-(cyclobutyl)-1,3-thiazol-2-amine
英文别名
4-Cyclobutyl-1,3-thiazol-2-amine
4-(cyclobutyl)-1,3-thiazol-2-amine化学式
CAS
475058-07-2
化学式
C7H10N2S
mdl
MFCD14706925
分子量
154.236
InChiKey
QCOWZNYRWUSFPN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    304.3±11.0 °C(Predicted)
  • 密度:
    1.283±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.571
  • 拓扑面积:
    67.2
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    4-(cyclobutyl)-1,3-thiazol-2-amineN-溴代丁二酰亚胺(NBS)N,N-二异丙基乙胺 、 N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate 作用下, 以 四氢呋喃N-甲基吡咯烷酮 为溶剂, 反应 11.33h, 生成 N-[4-cyclobutyl-5-(4-methylpiperazin-1-yl)-1,3-thiazol-2-yl]-5-methyl-1-(oxan-4-yl)-1H-pyrazole-4-carboxamide dihydrochloride
    参考文献:
    名称:
    Discovery of a novel orally active TRPV4 inhibitor: Part 1. Optimization from an HTS hit
    摘要:
    DOI:
    10.1016/j.bmc.2019.05.041
  • 作为产物:
    描述:
    参考文献:
    名称:
    Drug efflux pump inhibitor
    摘要:
    一种用于预防和/或治疗微生物感染的药物,其活性成分表示为以下一般式(I)的化合物: 其中,R1和R2代表氢原子、卤素原子、羟基或类似物,W1代表—CH═CH—、—CH2O—、—CH2CH2—或类似物;R3代表氢原子、卤素原子、羟基或氨基;R4代表氢原子、—OZ0-4R5(Z0-4代表烷基链、氟取代的烷基链或单键,R5代表环烷基、芳基或类似物);W2代表单键或—C(R8)═C(R9)—(R8和R9代表氢原子、卤素原子、较低烷基或类似物,Q代表酸性基团,但W2和Q可以共同形成乙烯基噻唑二酮或等效的杂环环;m和n代表0到2的整数,q代表0到3的整数。
    公开号:
    US20030092720A1
点击查看最新优质反应信息

文献信息

  • [EN] FUSED IMIDAZOLE CARBOXAMIDES AS TRPV3 MODULATORS<br/>[FR] CARBOXAMIDES D'IMIDAZOLE FUSIONNES UTILISES EN TANT QUE MODULATEURS DU TRPV3
    申请人:GLENMARK PHARMACEUTICALS SA
    公开号:WO2010070452A1
    公开(公告)日:2010-06-24
    The present invention provides transient receptor potential vanilloid (TRPV) modulators of formula (I). In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPV3. Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRP V3.
    本发明提供了化学式(I)的暂时性受体电位香草醛(TRPV)调节剂。具体来说,本文描述的化合物对于治疗或预防由TRPV3调节的疾病、症状和/或疾病非常有用。本文还提供了制备所述化合物的方法、用于合成的中间体、其药物组成以及治疗或预防由TRPV3调节的疾病、症状和/或疾病的方法。
  • FUSED IMIDAZOLE CARBOXAMIDES AS TRPV3 MODULATORS
    申请人:Chaudhari Sachin Sundarlal
    公开号:US20100152192A1
    公开(公告)日:2010-06-17
    The present invention provides transient receptor potential vanilloid (TRPV) modulators of formula (I). In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPV3. Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPV3.
    本发明提供了化学式(I)的暂时性受体电位香荚蒾(TRPV)调节剂。具体来说,本文描述的化合物对于治疗或预防由TRPV3调节的疾病、症状和/或疾病是有用的。本文还提供了制备所述化合物的方法、用于合成的中间体、其药物组成物,以及治疗或预防由TRPV3调节的疾病、症状和/或疾病的方法。
  • Medicine for inhibiting drug elimination pump
    申请人:Nakayama Kiyoshi
    公开号:US20050009843A1
    公开(公告)日:2005-01-13
    A medicament for preventive and/or therapeutic treatment of a microbial infection which comprises as an active ingredient a compound represented by the following general formula (I): wherein, R 1 and R 2 represent hydrogen atom, a halogen atom, hydroxyl group or the like, W 1 represents —CH═CH—, —CH 2 O—, —CH 2 CH 2 — or the like; R 3 represents hydrogen atom, a halogen atom, hydroxyl group or an amino group; R 4 represents hydrogen atom, a group of —OZ 0-4 R 5 (Z 0-4 represents an alkylene group, a fluorine-substituted alkylene group or a single bond, and R 5 represents a cyclic alkyl group, an aryl group or the like); W 2 represents a single bond or —C(R 8 )═C(R 9 )—(R 8 and R 9 represent hydrogen atom, a halogen atom, a lower alkyl group or the like, Q represents an acidic group, but W 2 and Q may together form vinylidenethiazolidinedione or an equivalent heterocyclic ring; m and n represent an integer of 0 to 2, and q represents an integer of 0 to 3.
    预防和/或治疗微生物感染的药物,其活性成分为以下通用式(I)所表示的化合物:其中,R1和R2表示氢原子、卤原子、羟基或类似物,W1表示—CH═CH—、—CH2O—、—CH2CH2—或类似物;R3表示氢原子、卤原子、羟基或基;R4表示氢原子、—OZ0-4R5(Z0-4表示烷基、代烷基或单键,R5表示环烷基、芳基或类似物);W2表示单键或—C(R8)═C(R9)—(R8和R9表示氢原子、卤原子、低烷基或类似物,Q表示酸性基团,但W2和Q可以共同形成乙烯基噻唑烷二酮或等效的杂环环;m和n表示0至2的整数,q表示0至3的整数。
  • Fused imidazole carboxamides as TRPV3 modulators
    申请人:Glenmark Pharmaceuticals, S.A.
    公开号:US08318928B2
    公开(公告)日:2012-11-27
    The present invention provides transient receptor potential vanilloid (TRPV) modulators of formula (I). In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPV3. Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPV3.
    本发明提供了式(I)的瞬时受体电位香草醛(TRPV)调节剂。特别地,本文所描述的化合物对于治疗或预防受TRPV3调节的疾病、状况和/或疾病是有用的。本文还提供了用于制备所述化合物的过程,用于其合成的中间体,其制药组合物以及治疗或预防受TRPV3调节的疾病、状况和/或疾病的方法。
  • MEDICINE FOR INHIBITING DRUG ELIMINATION PUMP
    申请人:DAIICHI PHARMACEUTICAL CO., LTD.
    公开号:EP1389463A1
    公开(公告)日:2004-02-18
    A medicament for preventive and/or therapeutic treatment of a microbial infection which comprises as an active ingredient a compound represented by the following general formula (I): wherein, R1 and R2 represent hydrogen atom, a halogen atom, hydroxyl group or the like, W1 represents -CH=CH-, -CH2O-, -CH2CH2- or the like; R3 represents hydrogen atom, a halogen atom, hydroxyl group or an amino group; R4 represents hydrogen atom, a group of -OZ0-4R5 (Z0-4 represents an alkylene group, a fluorine-substituted alkylene group or a single bond, and R5 represents a cyclic alkyl group, an aryl group or the like); W2 represents a single bond or -C(R8)=C(R9)- (R8 and R9 represent hydrogen atom, a halogen atom, a lower alkyl group or the like, Q represents an acidic group, but W2 and Q may together form vinylidenethiazolidinedione or an equivalent heterocyclic ring; m and n represent an integer of 0 to 2, and q represents an integer of 0 to 3.
    一种用于预防和/或治疗微生物感染的药物,其活性成分包括由以下通式(I)代表的化合物: 其中,R1 和 R2 代表氢原子、卤素原子、羟基或类似基团;W1 代表-CH=CH-、-CH2O-、-CH2CH2-或类似基团;R3 代表氢原子、卤素原子、羟基或基;R4 代表氢原子、-OZ0-4R5 的基团(Z0-4 代表亚烷基、取代的亚烷基或单键,R5 代表环状烷基、芳基或类似基团);W2 代表单键或-C(R8)=C(R9)-(R8 和 R9 代表氢原子、卤素原子、低级烷基或类似基团,Q 代表酸性基团,但 W2 和 Q 可共同形成亚乙烯基噻唑烷二酮或等效的杂环;m 和 n 代表 0 至 2 的整数,q 代表 0 至 3 的整数。
查看更多